Q4 2024 Earnings Call Transcript January 31, 2025 AbbVie Inc. misses on earnings expectations. Reported EPS is $2.16 EPS, expectations were $2.98. Operator: Good morning and thank you for standing by.
Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of the disease across the world, drives the growth of the market David Correa Allied Market Research + 1 800-792-5285 ...
This article explores the primary differences between manganese and magnesium, as well as each nutrient's uses, deficiencies, and special considerations.
Biochemical analyses provide an answer to the question of how the gut bacterium Morganella morganii might contribute to some cases of major depressive disorder. Incorporation of an environmental ...
In a major breakthrough, researchers in the UK have discovered a potential root cause of inflammatory bowel disease (IBD), a condition that affects millions globally. The discovery could revolutionize ...
Mount Sinai researchers demonstrate how wearable technology and artificial intelligence revolutionize inflammatory bowel disease management, offering unprecedented early detection and personalized ...